Firstly they will not do a trading halt as they are dual listed on ASX and NASDAQ and trading halts on nasdaq dont happen.
Secondly I would love to see your indepth research that you base your value that AMGN put on UNS.
There are products that AMGN want that suit their new drugs regime that will enhance their ability to gain market share and I am betting that they will pay a fair price for exclusive use of certain delivery devices. Now where there may be a squeeze is the level of funds they invisage required to get this business rolling. Based on history UNS burns through cash. I believe there will be pressure to reduce cash burn by reducing r+d and focus on production of existing products.
UNS Price at posting:
21.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
